PD1 inhibitor

PD-1 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PD1 inhibitor, covering 2022-12-27 to 2022-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer [Phase 2]

See pricing